Optimized Treatment Relieves Pain in Chronic Pancreatitis

Share this content:
Optimized Treatment Relieves Pain in Chronic Pancreatitis
Optimized Treatment Relieves Pain in Chronic Pancreatitis

TUESDAY, Jan. 10, 2017 (HealthDay News) -- For most patients with chronic pancreatitis (CP), optimized medical and interventional treatment is associated with significant pain relief, according to a study published online Jan. 4 in the Journal of Gastroenterology and Hepatology.

For the study, researchers from the All India Institute of Medical Sciences in New Delhi enrolled 313 consecutive patients with CP (92 percent with abdominal pain) who were treated with a well-balanced diet, pancreatic enzymes, and antioxidants. If medical therapy failed, patients were offered endoscopic therapy and/or surgery.

The researchers found that the etiology of CP was idiopathic in 71.6 percent of the patients and alcohol in 26.2 percent. Significant pain relief was achieved at one-year follow-up in 84.7 percent of patients: 52.1, 16.7, 7.6, and 8.3 percent, respectively, with medical therapy, endoscopic therapy, surgery, and spontaneously. There was a significant decrease in the mean pain score, from 6.36 ± 1.92 to 1.62 ± 2.1. Among the 261, 218, 112, and 51 patients with abdominal pain followed up for three, five, 10, and 15 years, 54, 57.3, 60.7, and 68.8 percent, respectively, became pain-free at follow-up.

"Significant pain relief is achieved in the majority of patients with optimized medical and interventional treatment," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »